Skip to content

Resources

Advertorials

thumbnail

Interventional radiologists Thomas Albrecht and Roberto Iezzi share their experience performing TACE with degradable starch microspheres (DSM-TACE) using EmboCept S DSM 50 μm


EmboCept® S DSM 50 µm suspension for injection is an adjuvant in the intra-arterial treatment of inoperable liver tumours and lung tumours in combination with cytostatic agents, the aim of which is to optimise the intra-tumoral drug accumulation.

EmboCept® is a registered trademark of Magle PharmaCept GmbH.